Professor David Burgner is a practising paediatric infectious diseases physician, leads the Inflammatory Origins Group and co-leads the LifeCourse longitudinal observational cohorts initiative at Murdoch Children’s Research Institute. He holds major national and international clinical / research positions including leadership roles in ASID, ESPID, WSPID and is an AAHMS fellow.
Professor Burgner is an international authority on understanding the susceptibility and consequences to childhood infection and inflammation, particularly in relation to the development of cardiometabolic disease risk. He is an internationally recognised clinical and scientific leader in Kawasaki disease and has made major scientific, clinical and policy contributions to the Australian response to the COVID-19 pandemic, particularly the hyperinflammatory post-infectious syndrome (known as PIMS-TS or MIS-C) in children.
Professor David Burgner is a practising paediatric infectious diseases physician, leads the Inflammatory Origins Group and co-leads the LifeCourse longitudinal observational cohorts initiative at Murdoch Children’s Research Institute. He holds major...
Professor David Burgner is a practising paediatric infectious diseases physician, leads the Inflammatory Origins Group and co-leads the LifeCourse longitudinal observational cohorts initiative at Murdoch Children’s Research Institute. He holds major national and international clinical / research positions including leadership roles in ASID, ESPID, WSPID and is an AAHMS fellow.
Professor Burgner is an international authority on understanding the susceptibility and consequences to childhood infection and inflammation, particularly in relation to the development of cardiometabolic disease risk. He is an internationally recognised clinical and scientific leader in Kawasaki disease and has made major scientific, clinical and policy contributions to the Australian response to the COVID-19 pandemic, particularly the hyperinflammatory post-infectious syndrome (known as PIMS-TS or MIS-C) in children.
Top Publications
Noye, EC, Bekkering, S, Limawan, AP, Nguyen, MU, Widiasmoko, LK, Lu, H, Pepe, S, Cheung, MM, Menheniott, TR, Wallace, MJ, et al.
Postnatal inflammation in ApoE-/- mice is associated with immune training and atherosclerosis..
Clin Sci (Lond)
135(15)
:
1859 -1871
2021
view publication
Longmore, DK, Miller, JE, Bekkering, S, Saner, C, Mifsud, E, Zhu, Y, Saffery, R, Nichol, A, Colditz, G, Short, K, et al.
Diabetes and overweight/obesity are independent, non-additive, risk factors for the in-hospital severity of COVID-19: An international, multi-center retrospective analysis.
Atherosclerosis
331:
e169
2021
view publication
Bekkering, S, Saner, C, Novakovic, B, Mccallum, Z, Netea, MG, Riksen, NP, Sabin, MA, Saffery, R, Burgner, DP.
Functional and transcriptional differences in monocytes from children with obesity compared to children of healthy weight.
Atherosclerosis
331:
e32
2021
view publication
Matricciani, L, Paquet, C, Fraysse, F, Grobler, A, Wang, Y, Baur, L, Juonala, M, Nguyen, MT, Ranganathan, S, Burgner, D, et al.
Sleep and cardiometabolic risk: a cluster analysis of actigraphy-derived sleep profiles in adults and children..
Sleep
44(7)
:
2021
view publication
Kerr, JA, Liu, RS, Gasser, CE, Mensah, FK, Burgner, D, Lycett, K, Gillespie, AN, Juonala, M, Clifford, SA, Olds, T, et al.
Diet quality trajectories and cardiovascular phenotypes/metabolic syndrome risk by 11-12 years..
Int J Obes (Lond)
45(7)
:
1392 -1403
2021
view publication